MAPT and Alzheimer disease: In conclusion, as radiologic modalities that detect MAPT neuropathology and MAPT-related axonal damage continue to show promise for the in vivo diagnosis and prognostication for patients with early AD, it is critical that we have a full understanding of MAPT neuropathology propagation patterns in the aging human brain.